Abstract
Day-to-day variations in plasma theophylline concentrations at steady-state have been assessed in 29 hospital inpatients who required theophylline for obstructive airways disease. Plasma concentrations were measured at 09.00h and 14.00h for four consecutive days in the equilibrium state in 13 patients taking 350 mg/day and 16 patients taking 700 mg/day. Analysis of variance gave 95% confidence limits for day-to-day variation of +/- 2.9 micrograms/ml at 350 mg/day and +/- 4.8 micrograms/ml at 700 mg/day. In a separate study, compliance with sustained-release theophylline therapy has been assessed in a group of 63 patients receiving the drug in general practice but not attending hospital. Compliance was estimated by comparing plasma theophylline concentrations before and after a 7-day period of measured theophylline consumption and by tablet counting. Of the 63 patients, 16 had discontinued their theophylline prior to being contacted and two did so during the first week: these were considered non-compliant. Three patients had plasma concentrations which increased by more than the day-to-day variation for their dose level during monitored intake and one other took less than 80% of his tablets. These patients were also considered non-compliant. A further four patients in whom plasma theophylline levels were zero on at least one occasion during the study were also adjudged non-compliant. Thus non-compliance with prescribed theophylline dosage occurred in 26 (41.3%) of the patients studied. In the majority of these, treatment had been discontinued and the non-compliance was gross.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Eney R. D., Goldstein E. O. Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels. Pediatrics. 1976 Apr;57(4):513–517. [PubMed] [Google Scholar]
- Hendeles L., Weinberger M., Johnson G. Monitoring serum theophylline levels. Clin Pharmacokinet. 1978 Jul-Aug;3(4):294–312. doi: 10.2165/00003088-197803040-00003. [DOI] [PubMed] [Google Scholar]
- Johnston G. D., McDevitt D. G. Digoxin compliance in patients from general practice. Br J Clin Pharmacol. 1978 Oct;6(4):339–343. doi: 10.1111/j.1365-2125.1978.tb00861.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kelly J. G., Leahey W. J. Measurement of theophylline in plasma by high performance liquid chromatography. Br J Clin Pharmacol. 1976 Oct;3(5):947–948. doi: 10.1111/j.1365-2125.1976.tb00657.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LUNTZ G. R., AUSTIN R. New stick test for P.A.S. in urine. Report on use of "phenistix" and problems of long-term chemotherapy for tuberculosis. Br Med J. 1960 Jun 4;1(5187):1679–1684. doi: 10.1136/bmj.1.5187.1679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sublett J. L., Pollard S. J., Kadlec G. J., Karibo J. M. Non-compliance in asthmatic children: a study of theophylline levels in a pediatric emergency room population. Ann Allergy. 1979 Aug;43(2):95–97. [PubMed] [Google Scholar]
- Taggart A. J., Johnston G. D., McDevitt D. G. Does the frequency of daily dosage influence compliance with digoxin therapy? Br J Clin Pharmacol. 1981 Jan;11(1):31–34. doi: 10.1111/j.1365-2125.1981.tb01098.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Upton R. A., Thiercelin J. F., Guentert T. W., Wallace S. M., Powell J. R., Sansom L., Riegelman S. Intraindividual variability in theophylline pharmacokinetics: statistical verification in 39 of 60 healthy young adults. J Pharmacokinet Biopharm. 1982 Apr;10(2):123–134. doi: 10.1007/BF01062330. [DOI] [PubMed] [Google Scholar]